This paper was prepared for the Professional Standards and Practice Council, then chaired by Dr. Nady el-Guebaly and now chaired by Dr. Werner Pankratz, and approved in principle by the Board of Directors of the Canadian Psychiatric Association in October 1984. Final approval by the Executive on May 21st, 1986.
References
1.
BlankR.J.Drug ads and the resident.Psychiatric News1981; Feb. 6.
2.
ParishP.A.Drug prescribing — the concern of all.R Soc Health J1973; 93 (4): 213–217.
3.
WilsonC.W.M., BanksJ.A., ReaMapes, KorteS.M.T.Influence of different sources of therapeutic information on prescribing by general practitioners.Br Med J1963; September 7: 599–607.
4.
WadeO.L.Adverse reactions to drugs.London: William Heinemann Medical Books Ltd., 1970.
5.
RosserW.W.Improving benzodiazepine prescribing in family practice through review and education.Can Med Assoc J1981; Jan. 15, 124(2): 147–153.
6.
BainD.J., HainesA.J.A year's study of drug prescribing in general practice using computer assisted records.JR Coll Gen Pract1975; 25: 41–48
7.
ParishP.A.The prescribing of psychotropic drugs in general practice.JR Coll Gen Pract1971; 21(suppl 4): 1–77.
8.
O'ConnorJ.F.Research, critical thinking and the pharmaceutical industry.Editorial, Nova Scotia Med Bull1983; June/Aug.: 66–67.
9.
GoldJ.Personal Communications, 1983.
10.
WoodsD.And now, a word for our sponsor.Can Med Assoc J June 21,1980; 122: 1343.
11.
Clinical review: abstracts from the world of psychiatry.Publ Trimel Communications Inc for Rhône-Poulenc.Ed. Eugene Melnyk.
12.
Intelligence reports in psychiatric disorders.Publ Health Scan Inc. for Lederie Laboratories. Ed. Robert Cancro.
13.
Psychiatry in the 80's.Ideas. Research. Practice. Publ Exerpta Medica for Hoechst. Ed. Max Hamilton.
14.
Focus/psychiatric practice.Publ Communications Media for Education, under a Grant-in-Aid from Bristol Laboratories of Canada.Canadian Editorial Advisory Board.
15.
StetlerC.J.Patterns of prescription drug use: the role of promotion.J Drug Ed1973; 3 (4): 389–402.
16.
BalterM., LevineJ.Character and extent of psychotherapeutic drug usage in the United States. 1970 Paper presented at the Fifth World Congress on Psychiatry in Mexico City Nov. 30, 1971.
17.
ColemanJ.S., KatzE., MenzelH.Medical innovation, a diffusion study.Bobbs-Merrill Company, Inc., 1966.
18.
Pharmaceutical Manufacturers Association of Canada — The effectiveness of pharmaceuticals and vaccines in containing other health care costs and their contribution to the economy of the nation, 1984.
19.
GrayC.The pharmaceutical industry: promoting research in the 80's.Can Med Assoc J March 15,1981; 124: 787–792.
20.
GrayC.The pharmaceutical industry — will Canada become a major research centre?Can Med Assoc J April 1,1981; 124: 910–918.
21.
Pharmaceutical manufacturers association of Canada — Principles of Ethical Drug Promotion, Code of Marketing Practice. Reprinted 1983.
22.
McAdamW Murray.Ont Med Assoc, Presidential Letter, June 3, 1983.
23.
FoulksJ.G.Letter, Can Med Assoc J August 15, 1982; 127: 273–274.
24.
PostlewaiteG.Letter, Can Med Assoc J August 15, 1982; 127: 274.
25.
Compendium of Pharmaceuticals and Specialties1984, 19th Ed.Pub. Canadian Pharmaceutical Association. Ed. Carmen M.E. Krogh.
26.
Physicians Reference Manuals.Drugs in Psychiatry, Nov. 1984Publ STA Communications Inc. Ed. A.W. Montgomery and M.D. Lapierre.
27.
SackettD.L.How to read clinical journals: V: to distinguish useful from useless or even harmful therapy.Can Med Assoc J May 1,1981; 124 (9): 1156–1162.
28.
el-GuebalyN.Personal Communication.
29.
PAAB Code of Advertising Acceptance. Publ. by the Pharmaceutical Advertising Advisory Board (PAAB), 345 Kingston Rd., Pickering, Ontario L1V 1A1.
30.
Royal College of Physicians & Surgeons of Canada.Atlantic Provinces Regional Advisory Committee Newsletter, July 1981.
31.
Can Med Assoc General Council Report, October 1983, Guidelines for Acceptance of Pharmaceutical Company financing of Continuing Medical Education courses and meetings.
